Detalles de la búsqueda
1.
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
Int J Clin Oncol
; 28(1): 79-88, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36414827
2.
Pembrolizumab plus pemetrexed-platinum for metastatic nonsquamous non-small-cell lung cancer: KEYNOTE-189 Japan Study.
Cancer Sci
; 112(8): 3255-3265, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036692
3.
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.
BMC Cancer
; 20(1): 115, 2020 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32046667
4.
Brigatinib-related organizing pneumonia mimicking pulmonary infection.
Jpn J Clin Oncol
; 54(3): 357-358, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38088031
5.
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
Int J Clin Oncol
; 24(7): 731-770, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31049758
6.
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
BMC Cancer
; 18(1): 946, 2018 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285770
7.
The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.
Jpn J Clin Oncol
; 48(1): 89-93, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29036303
8.
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 16(16): 1630-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522337
9.
Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.
Cancer
; 119(12): 2275-81, 2013 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23558513
10.
A phase II study of pemetrexed in chemotherapy-naive elderly patients aged ≥ 75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003).
Jpn J Clin Oncol
; 43(12): 1184-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24168805
11.
[A case of primary epiploic appendagitis of the sigmoid colon diagnosed by abdominal CT and managed conservatively].
Nihon Shokakibyo Gakkai Zasshi
; 109(5): 781-7, 2012 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-22688104
12.
Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review.
Intern Med
; 61(11): 1735-1738, 2022 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34803090
13.
Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET).
Transl Lung Cancer Res
; 10(1): 314-325, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569315
14.
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study.
Eur J Cancer
; 145: 183-193, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33486442
15.
[Case of hepatocellular carcinoma with abdominis muscle metastasis].
Nihon Shokakibyo Gakkai Zasshi
; 107(12): 1963-9, 2010 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-21139366
16.
The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients.
Respir Investig
; 58(4): 269-274, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32111518
17.
Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer.
Intern Med
; 57(9): 1269-1272, 2018 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29279482
18.
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).
Cancer Chemother Pharmacol
; 79(4): 689-695, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28280972
19.
Concurrent chemoradiotherapy with cisplatin and S-1 or vinorelbine for patients with stage III unresectable non-small cell lung cancer: A retrospective study.
Respir Investig
; 54(5): 334-40, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566381
20.
A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109).
Lung Cancer
; 87(2): 136-40, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25553650